Global, regional, and national burden of acute glomerulonephritis in children and adolescents
1990–2021 Analysis and Future Projections
Bibliographic Data
| ID | 22073269 |
|---|---|
| Authors | Ming Liu (0000-0003-3177-4001, Suizhou Central Hospital), Jing Liao (0000-0003-4870-2979, Children's Hospital of Chongqing Medical University), Yunpeng Gou (Suizhou Central Hospital), Ping Yang (0000-0002-3646-438X, Suizhou Central Hospital, corresponding author) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1677679-1677679 |
| Publication date | 2025-12-03 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1677679 |
| PMID | 41415256 |
| OpenAlex | W4416936170 |
| Language | EN |
| References cited | 40 |
Background: Acute glomerulonephritis (AGN) remains a significant issue in global health, yet its burden among children and adolescents has not been sufficiently characterized. This study aims to systematically estimate the global, regional, and national burden of AGN, as well as its temporal trends from 1990 to 2021. Methods: This study utilized data from the Global Burden of Disease (GBD) 2021 study, focusing on incidence rates, disability-adjusted life years (DALYs), and mortality among individuals under 20 years of age. Estimated annual percentage changes (EAPCs) were employed to assess temporal trends, and statistical analyses were conducted to examine correlations with the Socio-Demographic Index (SDI). Additionally, we performed decomposition and inequality analyses, along with Bayesian Age-Period-Cohort (BAPC) analyses, to evaluate trends and distributions related to the burden of AGN. Results: From 1990 to 2021, the global burden of AGN among children and adolescents remained significantly high. In 2021, there were approximately 170,584 new cases, representing a decrease compared to earlier years, with an age-standardized incidence rate (ASIR) of 6.47 per 100,000 (95% UI: 4.79-8.45). The EAPC for incidence showed a declining trend of -1.03% (95% CI: -1.15, -0.92). The total number of DALYs associated with AGN was 59,588.50 (95% UI: 32,925.73-79,649.94), with an age-standardized DALY rate of 2.26 per 100,000 (95% UI: 1.25-3.02), demonstrating a significant decline represented by an EAPC of -4.33% (95% CI: -4.46, -4.21). Gender differences were minimal; however, disparities across SDI regions were pronounced, with middle SDI regions exhibiting the highest incidence rate at 8.87 per 100,000, and increasing incidence rates observed in lower-middle and low SDI regions. Notably, China reported the highest number of cases, followed by Brazil and India. Furthermore, absolute inequality among SDI countries improved from 1990 to 2021, while relative inequality intensified during the same period. Conclusion: This study underscores the substantial and evolving burden of AGN among children and adolescents, highlighting the urgent need for targeted public health strategies and interventions to address disparities in disease burden and improve health outcomes in vulnerable populations
Acute glomerulonephritis · Burden of disease · Disease · Disease burden · MEDLINE · Psychological intervention · Public health · Chronic Kidney Disease and Diabetes · Renal Diseases and Glomerulopathies · Vasculitis and related conditions
Tackling socioeconomic inequalities and non-communicable diseases in low-income and middle-income countries under the Sustainable Development agenda
Burden of disease scenarios for 204 countries and territories, 2022–2050
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
| Citation velocity | historical |
|---|---|
| Highly cited | No |